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Background: Diabetic retinopathy is a serious sight-threatening complication 
which is manifested by excessive angiogenesis in diabetic patients. 
Aim: We hypothesize that cultured Rhesus monkey retinal endothelial cells 
(RhRECs) respond to high glucose with a change in cell proliferation and vascular 
endothelial growth factor (VEGF) secretion. 
Materials and methods: In our study, 20 000 cells per well were treated without 
glucose or with 5.5 mM, 18.5 mM and 30 mM glucose for 24 hours. Viable cells 
were counted using trypan blue dye exclusion method. VEGF concentrations were 
measured in cell media by ELISA method. 
Results: The number of viable cells incubated with 5.5 mM glucose increased sig-
nifi cantly by 53.7% after 24 hours. In comparison, the number of viable cells de-
creased by 2.8% at 18.5 mM of glucose and by 20.4% at 30 mM of glucose after 24 
hours of incubation. In contrast to this eff ect of glucose on the number of viable 
cells, a signifi cant increase in VEGF levels (pg/mL) in the cell media with a glucose 
concentration of 0 mM compared to 5.5 mM of glucose was found. VEGF secre-
tion in cell medium with 18.5 and 30 mM of glucose increased non-signifi cantly in 
comparison with euglycemic levels. 
Conclusion: Our results show that viability of retinal endothelial cells and VEGF 
release are highly responsive to changes in glucose concentration. Such glucose- 
induced changes in retinal endothelial cells may negatively impact the integrity 
of the microvasculature in the diabetic retina leading to angiogenesis and micro-
aneursym.
BACKGROUND
Diabetes mellitus is a metabolic disorder character-
ized by high levels of glucose in the blood (hyper-
glycemia). Diabetes is highly prevalent in developing 
countries and is estimated to affect approximately 
439 million people by 20301, suggesting that diabetes 
is a global health problem. This chronic disease has 
long term effects on kidneys, nerves, the heart, and 
other major organs. One such complication affects 
the eye and is known as diabetic retinopathy (DR). 
DR is one of the leading causes for blindness which 
affects approximately 93 million people worldwide. 
The key determinants in development of DR are 
diabetic duration and glycemic control.2 In the 
United States, 1 out of 12 persons with diabetes 
mellitus, age 40 and older, have advanced vision 
threatening retinopathy.3
Neurodegeneration is an initial process in the 
development of DR. Oxidative stress, hypoxia, 
high levels of glutamate, the induction of the 
renin-angiotensin system, and the elevated levels 
of receptor for advanced glycation endproducts are 
important factors included in the retinal neurodegen-
eration caused by diabetes mellitus.4 Somatostatin, 
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pigment epithelium-derived factor, and erythro-
poietin are neuroprotective peptides that play an 
essential role in retinal homeostasis, but they are 
decreased in the eye in diabetic patients. On the 
contrary, insulin-like growth factor 1 and vascular 
endothelial growth factor (VEGF) are key proteins 
involved in the development of new capillaries 
and fi nally cause damage of neurons in the retina. 
Thus the angiogenesis is a signifi cant process in 
the development of diabetic retinopathy. VEGF, a 
strong controller and promoter of angiogenesis, is 
a specifi c mitogen that induces new blood vessel 
formation by targeting growth and differentiation 
of endothelial cells.5 In many diabetic patients, 
VEGF is excessively produced in retina resulting 
in the proliferation of endothelial cells, new blood 
vessel formation, thus contributing to abnormali-
ties such as microaneurysms6, fl uid leakage, and 
tissue damage. 
In the last years, the knowledge about the 
pathogenesis of retinal neurodegeneration includ-
ing the function of growth factors has grown; 
however, follow-up research in this fi eld is needed 
to clarify the basic processes that contribute in 
retinal neurodegeneration and its connections with 
damage of the capillary blood vessels. Based on 
the above motioned results, we hypothesize that 
changes in glucose concentration will signifi cantly 
impact the viability of retinal endothelial cells and 
their VEGF secretion.
MATERIALS AND METHODS
CELL CULTURE
Rhesus monkey retinal endothelial cells (trans-
formed) were purchased from American Type Culture 
Collection (ATCC) (Catalog number: CRL 1780). 
Minimum Essential media Alpha (supplemented 
with 10% FBS, purchased from Life Technologies 
Co., Carlsbad, CA, USA) was used to revive cells 
in a T75 fl ask. The cells were stored in a 37°C 
incubator with 5% CO2 and the media changed 
every 48 hours. Confl uent cells were harvested as 
per manufacturer’s instructions and plated at 20 000 
per well (T0). After cells were allowed to settle (24 
hours), they were treated without glucose (hypogly-
cemic conditions; 0 mM), physiological glucose (5.5 
mM), hyperglycemic glucose (18.5 mM), or severe 
hyperglycemic conditions (30 mM). Each condi-
tion was measured in triplicate. After 24 hours of 
treatment, the cell media was collected and stored 
at -20°C (to be later used for cytokine analysis by 
ELISA). Cells were then harvested from each well 
using trypsin EDTA as per manufacturer’s instruc-
tions and prepared for trypan blue dye exclusion 
in order to determine the viable cell number (see 
trypan blue dye exclusion method below).
GLUCOSE TREATMENTS
Serum free media was used for the hypoglycemic 
(5.5 mM) condition. For 5.5, 18.5, and 30 mM 
treatments, D-(+)-Glucose (Catalog Number: G7021; 
Sigma Aldrich) was added to and dissolved in serum 
free medium at least one hour in advance before 
being introduced to the cells. Serial dilutions were 
necessary to derive the specifi c concentration for 
each treatment group. 
TRYPAN BLUE DYE EXCLUSION METHOD
Trypan blue dye exclusion method was used to 
determine number of viable cells present at T0 and 
after 24 hours glucose treatment. The cells were 
diluted 1:1 (volume: volume) using Trypan Blue 
(Corning, catalog number: 25-900 Cl) according to 
manufacturer’s instructions, before counting using 
a Neubauer’s hemocytometer.
hVEGF ELISA
Conditioned medium was harvested as noted above 
and kept at -20ºC overnight for ELISA. Human VEGF 
ELISA (Category Number DVE00; R&D Systems) 
was performed as per manufacturer’s instructions 
and analyzed using a DYNEX MRXII plate reader 
equipped with Revelation software or BIORAD 
microplate reader with Manager Software. Data 
was quantifi ed in comparison to VEGF standards.
STATISTICAL ANALYSIS
Statistical analysis was performed using GraphPad 
Prism Software (Version 6.07). All data were ex-
pressed as mean ± SEM (n=3 for 0, 5.5 and 30 mM 
and n=2 for 18.5 mM). Mean differences between 
groups were calculated using One-way ANOVA 
(with Dunnett’s Multiple Comparison Post-hoc Test). 
P<0.05 was considered to be statistically signifi cant.
RESULTS
CONCENTRATION-DEPENDENT CHANGES IN CELL VIABILITY
At T0 (the beginning of experiment), 20 000 vi-
able cells in each well were used in experiment. 
Fig. 1 shows RhRECs growth under hypoglycemic 
conditions (0 mM), physiological conditions (5.5 
mM), and at hyperglycemic conditions (18.5 or 30 
mM of glucose) after a period of 24 hours. Cells 
exhibited elongated shape with morphology indica-
tive of the cells of smooth muscle origin. Image of 
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cells in 5.5 mM of glucose shows large increase 
in confl uence from T0 (Fig. 1). In comparison, im-
ages from cells in 0 mM and 30 mM show large 
decreases in confl uence and a notable decrease 
was also observed in 18.5 mM of glucose. After 
24 hours of glucose treatment, the cells in 5.5 mM 
of glucose increased from 20 000 to 30 741 cells 
(increase by 53.7%) and the cells in 18.5 mM and 
30 mM decreased to 19 444 or 15 926 respectively 
(decrease by 2.8% and 20.4%) (Fig 2). Cells in 0 
mM of glucose decreased from the initial number 
to 13 333 (decrease by 33.3%). A concentration 
dependent signifi cant changes were observed when 
we compared the physiological glucose conditions 
(5.5 mM) with the cells incubated in hyperglycemic 
(18.5 mM and 30 mM) and hypoglycemic condi-
tions (0 mM). One-way ANOVA was signifi cant 
for a glucose effect on cell viability (P≤0.00004). 
Dunnett’s multiple comparison test suggests that the 
change in glucose concentration from 5.5 mM to 
0, 18.5, and 30 mM results in signifi cant changes 
in cell viability (Fig. 2).
CONCENTRATION-DEPENDENT CHANGES IN VEGF LEVELS 
IN CELL MEDIA
Fig. 3 shows VEGF levels in cell medium after a 
24 hour period of glucose treatment. In compari-
son to VEGF levels in cell media of cells grown 
in euglycemic glucose of 5.5 mM, increasing glu-
cose concentration of 18.5 or 30 mM resulted in 
a progressive increase in VEGF levels in the cell 
medium. This result points out to fact that the higher 
glucose induced more VEGF synthesis and release 
from RhRECs. However, RhRECs grown in 0 mM 
glucose conditions secreted a signifi cantly higher 
amount of VEGF compared to 5.5 mM of glucose 
(P≤0.0052). The VEGF levels produced by RhRECs 
found in the media were as follows: 146.3 pg/ml 
(0 mM of glucose), 22.6 pg/ml (5.5 mM), 28.0 pg/
ml (18.5 mM), and 37.6 pg/ml (30 mM) (Fig. 3).
Figure 1. Photomicrographs of RhRECs grown in 0, 5.5, 18.5, and 30 mM glucose for 24 hours.
Images from cells in 5.5 mM (Fig. 1B) show 75% confl uence, a signifi cant increase from T0 (60%). In comparison, 
images from cells in 0 mM (Fig. 1A) and 30 mM (Fig. 1D) show 45% and 50% confl uence, a signifi cant decrease 
from T0 density and a notable decrease in confl uence was observed in cells incubated at 18.5mM (Fig. 1AC). All 
images were taken at 100x magnifi cation.
1A 1B
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The VEGF levels per cell (pg/cell) were calcu-
lated by dividing the VEGF levels in cell medium 
with the respective cell number. After 24 hours 
treatment, each cell in 5.5 mM glucose secreted 
0.00073 pg of VEGF per cell, which was doubled 
when the glucose concentration was increased to 
18.5 mM (0.0015 pg/cell) and tripled when glucose 
concentration was further increased to 30 mM (0.002 
pg/cell). A 13-fold increase was observed in cells 
grown in 0 mM glucose (0.01 pg/cell). One way 
ANOVA showed a highly signifi cant glucose effect 
on VEGF secretion (pg/cell; P≤0.00023) (Fig. 4).
Figure 2. Concentration-dependent change in cell vi-
ability. RhRECs were plated at 20 000 per ml in a 24 
well plates. After 24 hours of glucose treatment, the 
changes in the number of viable cells in medium were 
found: 13 333 cells in 0 mM, 30 741 cells in 5.5 mM, 
19 444 cells in 18.5 mM, and 15 926 cells in 30 mM. 
One-way ANOVA determined signifi cant differences 
between groups (F/3.7/=50.48, P=0.00004). A Dunnett’s 
multiple comparison test was performed using 5.5 mM 
as control (**P<0.0001).
Figure 3. Concentration-dependent change in VEGF 
secretion per mL. After 24-hour glucose treatment, 
VEGF amounts secreted into conditioned medium was 
measured by ELISA. RhRECs secreted 146.3 pg/ml of 
VEGF in cell media with 0 mM of glucose, 22.6 pg/
mL (5.5 mM), 28 pg/mL (18.5 mM), and 37.6 pg/mL 
(30 mM). One-way ANOVA analysis found a signifi -
cant difference (F/3,7/=10.74, P=0.0052). A Dunnett’s 
multiple comparison test was performed using 5.5 mM 
as control (**P<0.05).
Figure 4. Concentration dependent changes in VEGF 
secretion per cell. VEGF secretion per cell was calcu-
lated by dividing VEGF levels measured in cell medium 
with the respective cell number. After 24 hours of glu-
cose treatment, the changes in VEGF secretion per cell 
were found: 0.01 pg/cell (in 0 mM of glucose), 0.00073 
pg/cell (5.5 mM), 0.001 pg/cell (18.5 mM), and 0.0023 
pg/cell (mM). Results from one-way ANOVA showed 
signifi cant difference (F/3,7/=14.17, P=0.0023). A Dun-
nett’s multiple comparison test was performed using 5.5 
mM as control (**P<0.05). 
DISCUSSION
In the present study, we have observed the changes 
in cell confl uence and viability of RhRECs over a 
24-hour period which were dependent on glucose 
concentration. Physiological glucose signifi cantly 
increased cell number but hyper- or hypoglycemic 
conditions induced a signifi cant decrease in cell 
number (Fig. 2). Our results validate the hypothesis 
that a change in glucose concentration induces change 
in the number of RhRECs. It is of great interest to 
point out the 18.5 mM glucose treatment did not 
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result in a large change in cell number compared 
to T0. When related to diabetic conditions in hu-
mans, it is possible that uncontrolled hyperglycemic 
conditions in excess of plasma levels of 18.5 mM 
may result in a large reduction in retinal endothelial 
cells leading to complications such as angiogenesis 
and microaneurysms. We have previously reported 
that treatment of high glucose (18 mM, 33 mM and 
40 mM) for a period of 5 days caused signifi cant 
decreases in cell viability in primary human retinal 
pericytes.7 When ARPE 19 cells were treated with 
high glucose (18 mM) for 8 days, it resulted in a 
signifi cant increase in cell viability.8
This study clearly showed that changes in glucose 
concentrations in RhRECs resulted in a signifi cant 
increase in VEGF levels in the conditioned media 
(Fig. 3). Dunnett’s Multiple Comparison Test sug-
gests that the signifi cant change is due to difference 
between VEGF level in RhRECs treatment with 0 
mM or 5.5 mM. The amount of VEGF secreted per 
cell increased signifi cantly with changes in glucose 
concentration from 0, 18.5 or 30 mM compared 
to physiological conditions (Fig. 4). These results 
are consistent with our previous fi ndings where 
increasing glucose concentrations of 18.5 mM 
caused an increase in VEGF secretion per cell in 
both ARPE-19 cells and human retinal pericytes. 
In human synovial fi broblasts, increasing glucose 
concentration in cell medium to 33 mM glucose 
for a 24-hour period caused an increase in VEGF 
secretion by the cells into the medium.9 Earlier 
reports showed that high glucose induced changes in 
cell number of human retinal pericytes and ARPE-
19 cells which were accompanied with increased 
VEGF secretion in cell media.7,8 Furthermore, 
human umbilical vein endothelial cells (HUVEC) 
treated with high glucose (25 mM/L) resulted in 
a decrease in VEGF secretion in cell media.10 In 
another study, both high glucose and low glucose 
treatment resulted in increase in VEGF secretion 
in cell media of rat and human Müller cells (Tsin 
et al., unpublished observations). More recent re-
sults of Velanki et al.11 demonstrated that human 
(MIO-M1) and rat (rMC-1) Müller cells (glial cells 
of the retina) are highly responsive to changes in 
glucose concentrations. 30 mM compared to 5.5 
mM signifi cantly increased cell viability in both cell 
lines but induced a signifi cant decrease in VEGF 
secretion per cell in rMC-1 only (5.5 mM and 30 
mM in comparison with 0 mM). In both MIO-M1 
and rMC-1, the amount of VEGF secreted per cell 
increased by about 100% when glucose was changed 
from 5.5 to 0 mM but decreased slightly (17% in 
MIO-M1 and 11% in rMC-1) when glucose was 
increased from 5.5 to 30 mM. According to the 
authors, mechanisms remain unknown.
In the present study, it was observed that glucose 
deprived conditions induce more proangiogenic re-
sponse than high glucose conditions. It is not clear 
how VEGF affects RhRECs proliferation. Further 
studies are required to determine the interactive ef-
fect of glucose, VEGF, and RhRECs proliferation. 
It is possible that glucose may induce apoptosis 
of RhRECs via a molecular mechanism involving 
TGFβ similar to that reported earlier.12 Moreover, 
Jiang et al.13 demonstrated that eNOS and PKC 
signaling are included in the regulation of VEGF 
levels in diabetic retina. In another study, Joyal 
et al.14 summarized that impaired glucose entry 
into photoreceptors results in a dual (lipid and 
glucose) fuel shortage and a reduction in the lev-
els of the Krebs cycle intermediate α-ketoglutarate 
(α-KG). Low α-KG levels promotes stabilization 
of hypoxia-induced factor 1a and secretion of 
VEGF-A by starved Vldlr(-/-) photoreceptors, lead-
ing to neovascularization. The authors concluded 
that dysregulated lipid and glucose photoreceptor 
energy metabolism might be a driving force in 
several retinal diseases including DR. 
CONCLUSION
Overall, our data clearly suggests that glucose 
concentration has a signifi cant effect on viability 
of RhRECs in culture as well as their secretion 
of VEGF. Nevertheless, such glucose effects on 
RhRECs cell number and VEGF release are novel 
and potentially important and thus may provide 
innovative approaches to investigate the pathology 
of angiogenesis in diabetic retinopathy.
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Введение: Диабетическая ретинопатия является серьёзным угрожающим 
жизни осложнением, которое проявляется с избыточным ангиогенезом у 
больных сахарным диабетом. 
Цель: Мы высказываем гипотезу, что эндотелиальные клетки сетчатки лабо-
раторных макаков-резус (RhRECs) реагируют на высокие уровни глюкозы из-
менением клеточной пролиферации и секрецией фактора сосудистого роста 
эндотелия (ФСРЭ).
Методы: В нашем исследовании 20 000 клеток на лунку планшета были об-
работаны без глюкозы или с 5.5 mM, 18.5 mM и 30 mM глюкозы в течение 24 
часов. Количество жизнеспособных клеток было установлено при помощи 
метода исключения красителя Trypan blue. ФСРЭ концентрации были измере-
ны в клеточной среде при помощи метода ELISA.
Результаты: Количество жизнеспособных клеток, инкубированных 5.5 mM 
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глюкозы, увеличилось на 53.7 % через 24 часа. Для сравнения, количество 
жизнеспособных клеток уменьшилось на 2.8 % при 18.5 mM глюкозы и на 20.4 
% при 30 mM глюкозы после 24-часовой инкубации. В отличие от данного 
эффекта глюкозы на количество жизнеспособных клеток, было установлено 
значительное повышение ФСРЭ уровней (pg/mL) в клеточной среде с кон-
центрацией глюкозы 0 мM по сравнению с 5.5 mM глюкозной концентрацией. 
ФСРЭ секреция в клеточной среде с 18.5 и 30 mM концентрацией глюкозы 
повысилось незначительно по сравнению с нормальным уровнем. 
Заключение: Наши результаты показывают, что жизнеспособность эндотели-
альных клеток сетчатки и освобождение ФСРЭ проявляют высокую степень 
чувствительности на изменения в концентрации глюкозы. Установленные 
изменения, индуцированные глюкозой, у эндотелиальных клеток сетчатки 
могут повлиять отрицательным способом на целостность микрососудов диа-
бетической сетчатки, что приведёт к ангиогенезу и микроаневризме. 
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